INmune Bio Inc. - Amendment to Warrants

INmune Bio Inc. has entered into an amendment to warrants previously issued in April 2024. The exercise price for 1,348,315 outstanding warrants has been reduced to $1.95, which is above the Nasdaq minimum price. The expiration date for these warrants has been extended to June 30, 2026. As consideration for this amendment, warrant holders paid $0.05 per warrant, totaling $67,416 in proceeds for the company. The amendment is effective upon receipt of payment and a duly executed copy of the amendment from the warrant holders, with an execution deadline of December 22, 2025.